Andes is a Biotech company based in Emeryville, California. It has raised $15M in total funding. Latest round: Series A.
Andes funding overview
Andes is a Biotech company based in Emeryville, California. Andes has raised $15M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series A announced in September 2021. The round record for Andes runs through 2021; nothing later has been disclosed. Investors on record include Leaps by Bayer, Cavallo Ventures, Builders VC, Germin8, Accelr8, Wilson Sonsini and 2 others. 8 distinct backers are named across the disclosed rounds.
Andes at a glance
Total raised
$15M
Latest round
Series A
Latest round date
September 2021
Industry
Biotech
Headquarters
Emeryville, California
Notable investors
Leaps by Bayer, Cavallo Ventures, Builders VC, Germin8, Accelr8, Wilson Sonsini, KdT Ventures, Endurance
Frequently asked about Andes funding
How much has Andes raised?
Andes has raised $15M in total disclosed funding across the rounds on record.
Who has invested in Andes?
Leaps by Bayer, Cavallo Ventures, Builders VC, Germin8, Accelr8, Wilson Sonsini are named among the investors backing Andes.
What was the latest Andes funding round?
The most recent disclosed round is a Series A, announced in September 2021.
Where is Andes based?
Andes is based in Emeryville, California.
What sector does Andes operate in?
Andes is tracked under Biotech from Emeryville, California, with $15M in disclosed funding.
When did Andes last raise?
The last disclosed Andes round closed in September 2021 at Series A.
We update the Andes record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in Emeryville and their backers are listed below.
